Clinic Software← All companies
Genix Therapeutics
Genix Therapeutics is a niche, R&D stage, virtual pharmaceutical company focused on the identification and development of challenging generic injectable products.
healthcare / biopharma
Founded2005
Employees4
LocationChicago, IL
Business modelB2B, B2B2C, SaaS
About
Genix Therapeutics is an R&D stage virtual pharmaceutical company focused on identifying and developing complex generic injectable products. The company works with partners including suppliers, manufacturers, labs, and commercialization firms to overcome technical and supply challenges, with three lead assets in development targeting FDA approval. Genix serves pharma and biotech companies seeking complex generic injectable opportunities and conducts early-stage R&D, bioequivalence studies, stability studies, and regulatory submissions.
Product
- Value proposition
- Intense focus on a limited number of projects in collaboration with proven partners to increase probability of FDA approval and optimal commercial launch.
- Target customers
- pharma and biotech companies seeking complex generic injectable opportunities
- Regulatory
- pre-commercial / development stage; FDA-focused pathway
Founders
- Ragab El-Rashidy — Founder and CEO
Categories
Products
three complex generic injectable products (lead assets)
Key features
focused projects with partners (suppliers, manufacturers, labs, commercialization)early-stage R&DcGMP registration batchesstability studiesbioequivalence studiesFDA submissions and approval
Technologies
analytical methodsbioequivalence testingcGMP processesregulatory submission expertise
Integrations
FDAregulatory bodiesmanufacturerssuppliersanalytical labs
Target conditions
complex generic injectable productshigh-value injectable therapies
Care settings
R&D labvirtual/remote development environment
Certifications
FDA regulatory engagementcGMPFDA submissions and approval
Partnerships
proven partners (suppliers, manufacturers, labs, commercialization)global network of development and commercialization partners
Traction metrics
3 complex generic products identified for developmentready to be developed assets
Competitors
other players in complex generic injectablesmid- to large-cap pharma with generic strategies
News
- People Archive - Portal Innovations · 2025-10-31T00:00:00.000Z
- Genix Pharmaceuticals Closes Private Placement - BioSpace · 2025-09-04T20:50:27.000Z
- Genix Pharma Raises $100K in Private Placement from Insiders | GENPF Stock News · 2025-09-04T20:15:00.000Z
- Cambridge Healthcare Research's Post - Solici - LinkedIn · 2024-11-22T00:00:00.000Z
- GenixCure shifts from AAV vector to platform, targeting CNS and rare diseases with next-generation AAVs < The interview < ENGLISH NEWS < 기사본문 - 더바이오 · 2026-02-02T09:40:00.000Z
- Genix.AI Company Profile Funding & Investors | YourStory · 2026-04-26T00:00:00.000Z
